Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 1.17%, near the low end of its 5-year range (0.00%–4.97%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
1.17%
DEBT TO ASSETS RATIO AVG 10Y
0.97%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Adial Pharmaceuticals, Inc.
Market Cap
$11.42M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
1.17%
Market Cap
$11.01M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.95M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.46M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.27M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.63M
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.42M | 0.00% | 0.00% | 0.00% | 1.17% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | 0.31% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | 0.01% | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | 0.06% | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.02% | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | 0.00% | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | 0.69% | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | 0.00% | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | 0.30% | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | 0.71% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
5.63
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 4.97% |
| 2022-12-31 | 3.62% |
| 2022-09-30 | 2.84% |
| 2022-06-30 | 2.13% |
| 2022-03-31 | 1.76% |
| 2021-12-31 | 3.37% |
| 2021-09-30 | 2.57% |
| 2021-06-30 | 3.39% |
| 2021-03-31 | 3.63% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 2.64% |
| 2018-06-30 | 533.45% |
| 2018-03-31 | 1209.78% |
| 2017-12-31 | 1995.21% |
| 2017-09-30 | 653.99% |
| 2017-06-30 | 253.69% |
| 2017-03-31 | 272.85% |
| 2016-12-31 | 154.60% |
